Can we predict diabetes after a liver transplant?

NCT ID NCT06950788

Recruiting now Knowledge-focused Sponsor: University of Chicago Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 60 adults with cirrhosis who are waiting for a liver transplant but do not have diabetes. Researchers want to see if tests like glucose monitoring, oral glucose tolerance tests, and wrist activity trackers can predict who will develop diabetes after the transplant. Participants will wear monitors and take tests before and after their transplant.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors identify who is at risk for diabetes after a liver transplant, allowing for earlier monitoring or prevention.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly change patient care. The results may not apply to all patients or lead to clear risk factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSIS, LIVER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver disease related to transplantation Fibrosis liver failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CIRRHOSIS, LIVER DIABETES MELLITUS RISK TRANSPLANT-RELATED DISORDER TRANSPLANT; FAILURE, LIVER

Contacts and locations

Locations

University of Chicago Medical Center
RECRUITING

Chicago, Illinois, 60637, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.